ClinicalTrials.gg
RecruitingNCT05599750Updated Nov 16, 2026

Suture Repair vs Mesh Repair for Incisional Hernia

An interventional study of Incisional hernia repair in Incisional Hernia, sponsored by Clayton Petro. Recruiting at 5 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Clayton Petro · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Nov 2022; still recruiting 4 years later.
Updated Nov 16, 2026Primary completion movedStudy contact changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
154
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Incisional Hernia with a site in United States — 6 open to participants now, 8 under way, none of them phase 3. Incisional Hernia · United States.

Planned enrollment
6th of 20
154 · median 98
Started
2022
with 1 other
No phase
17 of 34
5 open now
Registered
27th of 34
by date
Lead sponsor
1 of 34
Clayton Petro

Among the 34 studies in Incisional Hernia with a site in United States, this one is the 6th largest by planned enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2022, is one of 17 with no phase, and was the 27th registered.

Incisional Hernia

212 studies on the registry are indexed under Incisional Hernia; 58 are open to participants now.

Browse Incisional Hernia studies →

Open to participants now

6 of the 34 studies in Incisional Hernia with a site in United States are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 39 Incisional Hernia studies recruiting now, 28 (72%) set no upper age limit and 2 (5%) stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Incisional Hernia with a site in United States, or all of them as a file.
02

Study summary

The goal of this randomized controlled trial is to compare the difference in quality of life at one year postoperatively for patients undergoing incisional hernia repair with mesh versus suture repair using modern techniques.

The main question it aims to answer are:

  • Determine if primary suture repair is non-inferior to mesh repair for incisional hernias 2-6cm with respect to quality of life using the HerQLes summary score at one year postoperatively.
Read the detailed description

This is a patient-blinded randomized control trial comparing incisional hernia repair using synthetic mesh versus suture repair. This is a non-inferiority trial theorizing that suture repair will be non-inferior with respect to quality of life (using the HerQLes survey) at 1 year postoperatively. Patients will be blinded to the intervention, groups will be in parallel.

03

Conditions studied

  • Incisional Hernia

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults >18 years old.
  • Anticipated hernia defect 2-6cm in width
  • Non-emergent case
  • CDC class I
  • Patients who previously underwent primary ventral hernia repair without the use of mesh
  • Incisional hernia

Exclusion criteria

Exclusion Criteria:

  • Emergent cases
  • Patients \< 18 years old
  • Patients who are pregnant
  • Patients who previously underwent a prior ventral hernia repair with mesh at the site of the intended repair. Abdominal mesh in separate locations would be allowed.
  • Ventral hernia \<2cm or > 6 cm in width
  • Primary hernia
  • CDC wound class II-IV
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
154 participants (estimated)

Study arms

  • Active comparator
    Hernia repair with mesh (Control arm)

    Participants will undergo incisional hernia repair with prolene mesh in the retrorectus position with at least 4cm of overlap.

    Procedure: Incisional hernia repair

  • Active comparator
    Primary closure (Intervention arm)

    Participants will undergo incisional hernia repair with suture alone using modern surgical techniques.

    Procedure: Incisional hernia repair

Interventions

  • ProcedureIncisional hernia repair

    Participants will undergo incisional hernia repair

06

What researchers measure

Primary outcomes

  1. Hernia specific quality of life

    Suture repair will be compared to mesh repair for incisional hernias 2-6cm with respect to quality of life using the Hernia-specific Quality of Life (HerQLes) summary score at one year postoperatively. This is reported as a score from 0-100 with higher numbers indicating better quality of life.

    Time frame: 1 year

Secondary outcomes

  1. Hernia specific quality of life

    Compare HerQLes summary score at baseline, 30-day, and 2-year follow-up, and 5-year follow up

    Time frame: 5 years

  2. PROMIS-3a-Pain Intensity scores

    Compare PROMIS-3a-Pain Intensity scores (a validated measure of pain) at baseline, 30-day, 1-year, 2 years, and 5- year follow up. Scores are reported as raw values from 3-15 or as T-scores from 30.7-71.8, with higher numbers indicating more pain.

    Time frame: 5 years

  3. Recurrence

    Compare composite recurrence using clinical, radiographic exam, and Hernia Recurrence Inventory (HRI) at 1-year, and 2-year, and 5 year follow-up postoperatively

    Time frame: 5 years

  4. Complications

    Compare all complications at 30-day, 1-year, 2-year, and 5-year follow-up postoperatively. This includes occurrence of surgical site infections, surgical site occurrence requiring intervention, readmissions, hernia related reoperation, or mortality.

    Time frame: 5 years

  5. Overall quality of life

    4\. Compare Euro-QOL-5D-5L with VAS assessment scores at baseline, 30-day, 1-year, 2 years, and 5-year follow-up.

    Time frame: 5 years

  6. Cost effectiveness

    5\. Perform a formal cost effectiveness analysis utilizing quality adjusted life years and incremental cost effectiveness ratios.

    Time frame: 5 years

07

Study locations

4 of 5 sites recruiting
08

References and documents

Publications

  • Maskal SM, Miller BT, Ellis RC, Beffa LRA, Prabhu AS, Rosen MJ, Krpata DM, Huang LC, Petro CC. A modern comparison of suture repair versus mesh repair for incisional hernia: a study protocol for a randomized controlled trial. Trials. 2025 Oct 29;26(1):450. doi: 10.1186/s13063-025-08924-5. PubMed 41163187 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2022 (actual). Primary completion is estimated for Oct 2028, 71 months after the start.

Of 60 non-industry interventional studies with no phase under Incisional Hernia, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 29 and three quarters within 60. This study's planned 71 months is above that.

Counting every sponsor, half of 67 studies reached it within 43 months; a quarter within 29 and three quarters within 60.

Primary completion moved once since we started tracking on Sep 25, 2026: Oct 2026 → Oct 2028, on Nov 16, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2022
First posted
Oct 31, 2022
StartActual
Nov 14, 2022
Primary completionEst.
Oct 2028was Oct 2026
CompletionEst.
Oct 2031
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 2026→Oct 2028
Nov 16, 2026
Contact
Study contact changed: b•••@ccf.org · •••8971→r•••@ccf.org · •••8971. See the current contact
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Primary completion Oct 2026→Oct 2028
    Contact Study contact changed: b•••@ccf.org · •••8971→r•••@ccf.org · •••8971. See the current contact
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05599750
Lead sponsor
Clayton Petro
Responsible party
Clayton Petro (Assistant Professor, The Cleveland Clinic) — Sponsor-investigator
First posted
Oct 31, 2022
Start date
Nov 14, 2022
Primary completion
Oct 2028 (estimated)
Completion
Oct 2031 (estimated)
Last update
Nov 16, 2026

Study contacts

Clayton Petro, MD
Contact
petroc@ccf.org
2169242930
Vishal Rajesh, MD
Contact
rajeshv@ccf.org
2163138971
Clayton Petro, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion